CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and allied products in Australia, the United States, Germany, the United Kingdom, Switzerland, China, and internationally. The company operates through two segments, CSL Behring and Seqirus. The CSL Behring segment offers plasma therapies for the treatment of immunodeficiency, bleeding disorders, hereditary angioedema, Alpha-1 antitrypsin deficiency, and neurological disorders. It also operates approximately 140 plasma collection centers. In addition, this segment conducts research on plasma and non-plasma therapies; and receives license and royalty from the commercialization of intellectual property. The Seqirus segment manufactures and distributes non-plasma biotherapeutic products; and developsinfluenza vaccines. CSL Limited was founded in 1916 and is headquartered in Parkville, Australia.
Industry, Sector and Symbol
Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
CIKN/A
Phone61-3-9389-1911
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$7.92 billion
Profitability
Miscellaneous
Employees22,000
Next Earnings Date8/20/2019 (Estimated)
OptionableNot Optionable
Commonwealth Bank of Australia (OTCMKTS:CSLLY) Frequently Asked Questions
What is Commonwealth Bank of Australia's stock symbol?
Commonwealth Bank of Australia trades on the OTCMKTS under the ticker symbol "CSLLY."
When is Commonwealth Bank of Australia's next earnings date?
Has Commonwealth Bank of Australia been receiving favorable news coverage?
Media stories about CSLLY stock have trended negative this week, according to InfoTrie. The research group identifies positive and negative media coverage by monitoring more than six thousand news and blog sources in real time. The firm ranks coverage of companies on a scale of negative five to five, with scores closest to five being the most favorable. Commonwealth Bank of Australia earned a daily sentiment score of -2.3 on InfoTrie's scale. They also gave news stories about the company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an effect on the company's share price in the near term. View News Stories for Commonwealth Bank of Australia.
Who are some of Commonwealth Bank of Australia's key competitors?
Some companies that are related to Commonwealth Bank of Australia include Novo Nordisk A/S (NVO), AstraZeneca (AZN), Eli Lilly And Co (LLY), Sanofi (SNY), GlaxoSmithKline (GSK), AbbVie (ABBV), Bristol-Myers Squibb (BMY), Celgene (CELG), Bayer (BAYRY), Zoetis (ZTS), Shire (SHPG), Allergan (AGN), Vertex Pharmaceuticals (VRTX), Regeneron Pharmaceuticals (REGN) and Shiseido (SSDOY).
Who are Commonwealth Bank of Australia's key executives?
Commonwealth Bank of Australia's management team includes the folowing people:
- Mr. Paul R. Perreault, MD, CEO & Exec. Director (Age 62)
- Mr. David Mark Lamont ACA, BCom, Chief Financial Officer (Age 53)
- Dr. Robert Andrew Cuthbertson, Chief Scientific Officer & Director of R&D and Director (Age 64)
- Mr. Gregory Boss BS(Hons), J.D., Exec. VP of Legal & Group Gen. Counsel (Age 58)
- Ms. Elizabeth Walker, Exec. VP & Chief HR Officer (Age 49)
How do I buy shares of Commonwealth Bank of Australia?
Shares of CSLLY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Commonwealth Bank of Australia's stock price today?
One share of CSLLY stock can currently be purchased for approximately $77.46.
How big of a company is Commonwealth Bank of Australia?
Commonwealth Bank of Australia has a market capitalization of $35.04 billion and generates $7.92 billion in revenue each year. The company earns $1.73 billion in net income (profit) each year or $1.91 on an earnings per share basis. Commonwealth Bank of Australia employs 22,000 workers across the globe.View Additional Information About Commonwealth Bank of Australia.
What is Commonwealth Bank of Australia's official website?
How can I contact Commonwealth Bank of Australia?
Commonwealth Bank of Australia's mailing address is 45 Poplar Road, Parkville C3, 3052. The company can be reached via phone at 61-3-9389-1911.
MarketBeat Community Rating for Commonwealth Bank of Australia (OTCMKTS CSLLY)
MarketBeat's community ratings are surveys of what our community members think about Commonwealth Bank of Australia and other stocks. Vote "Outperform" if you believe CSLLY will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CSLLY will underperform the S&P 500 over the long term. You may vote once every thirty days.
